Erin McEvoy

Here, we bring you our top five recent articles covering a $3.6 million grant for Minnesota’s cannabis industry, kidney disease and cannabis use, banking reform, flavoalkaloids in leaves, and CBD and liver enzyme levels.

Two organizations with opposing views recently prepared letters to the Trump Administration on the anticipated action regarding cannabis reclassification.

In collaboration with the California Department of Cannabis Control (DCC), the new feature is anticipated to increase direct access to recall information.

Using an optimized analytical method for this research, the phenolics of cannabis were tested resulting in new findings.

The FDA-funded study found that CBD was linked to elevated liver enzymes in some healthy adults, underscoring need for further safety research.

Here, we bring you our top four recent articles covering research on cannabinoids and sleep, why enrolled patients turn to illegal cannabis, using spent hemp biomass as livestock feed, and testing cannabinoids on breath after ingesting edibles.

The researchers measured the amount of THC and other cannabinoids on participants’ breaths, with results demonstrating an increase in THC concentration from baseline samples.

The exploratory analysis suggest that lower costs and reliable supply could affect reliance on illegal medical cannabis in Utah.

The study tracks how THC and CBD levels in cow milk, plasma, and fat tissue change during hemp feed intake and withdrawal periods.

In the second part of this webinar coverage, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

Here, we bring you our top five recent articles covering National CBD Day 2025, medical cannabis patients’ workers’ compensation, Trump looking into cannabis rescheduling, research studies on cannabis for sleep, and a clinical trial for CBD and insomnia.

In this month’s webinar, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

The referral-based partnership aims to provide cannabis businesses with comprehensive solutions that merge compliance, payroll, insurance, and risk management services.

President Trump recently stated interest in considering the reclassification of cannabis with an update on the decision anticipated within the coming weeks. Industry stakeholders, including CST blog author Kim Anzarut, weigh in.

House Bill 1766 proposes that qualifying employees receive up to $250 monthly and $3000 annually for approved medical cannabis purchases.

Here, we bring you our top five recent articles covering multiple stories on adult-use cannabis sales in Delaware, the top compliance issues in 2025, and research on how medical cannabis affects healthcare utilization by chronic pain patients.

Analysis of two coffee products revealed 70–80% less CBD in the brewed coffee than what was indicated on the label.

Researchers analyzed data from more than 5000 chronic pain patients across 36 US states.

Ayr Wellness secures support from a majority of senior noteholders, outlining a restructuring plan to stabilize operations and reduce debt.

Listen to Noid Factoid from Daniela Vergara, PhD, Hemp Specialist at the Cornell Cooperative Extension.

Here, we bring you our top five recent articles covering adult-use cannabis in Texas, the new DEA Administrator, hemp language in the senate agriculture bill, a new dispensary in Cleveland, and a $2.5 million lawsuit in Connecticut.

The Small and Homestead Independent Producers Act of 2025 aims to support small businesses though cannabis product shipping, once cannabis is removed from the Controlled Substances Act.

Industry stakeholders supported the removal of the language, which they said would have decimated the nation’s hemp industry.

A scoping review of 41 studies finds physicians nationwide report a lack sufficient training to counsel patients on medical cannabis use, with mixed perceptions on favorability of its use.

In a press release from the DEA, Cole presents his priorities as administrator, focusing on drug cartels and the drug crisis.

Here, we bring you our top five recent articles covering updates in Michigan, cannabis cultivation begins in Kentucky, a new cannabis education scholarship, and updates at the NCIA.

The technology platform will support fundraising, outreach efforts, and advocacy efforts for the nonprofit Mission [Green].

Cresco Labs CEO cites market fragmentation, price compression as key challenges in California.

Smith’s leadership and advocacy experience is anticipated to strengthen the organization’s mission of cannabis policy reform.

The company intends to divest 20 dispensaries and four cultivation facilities as part of strategic withdrawal and efforts to redirected growth.